Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.34 |
| ▸ | THRB | P10828 | 3/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.31 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.31 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754254 | 0.91 | AKR1C3 (0.35) | FFAR1THRBAKR1C3 | |
| SCHEMBL15582416 | 0.88 | THRB (0.38) | FFAR1THRBAKR1C3KMT2AMAPT | |
| SCHEMBL17754249 | 0.88 | THRB (0.43) | THRBAKR1C3KMT2AMAPT | |
| SCHEMBL17754262 | 0.86 | THRB (0.39) | THRBFFAR4AKR1C3KMT2AMAPT | |
| SCHEMBL17754252 | 0.86 | FFAR4 (0.35) | FFAR1THRBFFAR4AKR1C3KMT2A | |
| SCHEMBL17719440 | 0.86 | THRB (0.40) | FFAR1THRBFFAR4AKR1C3KMT2A | |
| SCHEMBL12733720 | 0.82 | THRB (0.40) | FFAR1THRBFFAR4AKR1C3 | |
| SCHEMBL15582417 | 0.81 | THRB (0.49) | FFAR1THRBFFAR4KMT2AMAPT | |
| SCHEMBL18541172 | 0.80 | THRB (0.37) | FFAR1THRBFFAR4AKR1C3KMT2A | |
| SCHEMBL17754246 | 0.80 | THRB (0.37) | FFAR1THRBFFAR4AKR1C3KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | RCC1, LPXN, SMC4 | FFAR1 1525/4885THRB 4879/4885FFAR4 1131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.